Richard and Susan Rogel’s record-breaking gift to Michigan Medicine — at $150 million — will transform cancer research.
So says a U-M study that looks at whether it’s best to start regular screening at 40 or 50.
New Forbes Institute for Cancer Discovery aligns University experts across disciplines to fuel rapid development of technology and therapies.
The drugs Avastin and Sutent have been looked at as potential breast cancer treatments. But while they do shrink tumors and slow the time till the cancer progresses, the effect does not last, and the cancer eventually regrows and spreads. Now U-M researchers have discovered why—and what can be done about it.